NOCD Announces Noto As New Parent Brand, Acquires Rebound Health for PTSD

World’s largest virtual specialty therapy company announces its AI-enabled platform, Noto, as its new parent brand, positioned to power and transform the future of specialty therapy for complex psychiatric and behavioral conditions (CPBCs).

CHICAGO--(BUSINESS WIRE)--This week NOCD, the world’s largest specialty behavioral health treatment company and leader in serving OCD and Related Disorders, announced that Noto, the AI-enabled platform built from scaling NOCD over the past decade, will serve as its new parent brand. In Latin, Noto means “to be known.” Virtual specialties powered by Noto will help people with complex psychiatric and behavioral conditions know what they're experiencing, access evidence-based treatment, and get better.

The Noto platform has enabled NOCD to deliver over 1 million evidence-based OCD therapy sessions per year, with industry-leading clinical outcomes. Now, Noto is poised to power the next generation of virtual specialties for other complex psychiatric and behavioral conditions, starting with the acquisition of Rebound Health for Trauma Disorders. Noto will serve as the parent brand for both NOCD and Rebound, enabling both to continue scaling nationwide.

Stephen Smith, Co-Founder and CEO of Noto and NOCD, shares the origins of the Noto platform: “We set out to develop a better treatment system that identifies hard-to-reach people with OCD, builds trust with them, and offers them effective, affordable, and convenient care for the root of their suffering, rather than surface-level symptoms. This led to world-class clinical outcomes for our therapy members and substantial savings for our payer partners, allowing us to re-invest in serving more people in need of care. Today, we’ve engaged millions in our online community and enrolled hundreds of thousands in specialized therapy. We couldn’t have scaled to this point if we hadn’t created Noto: the natively-built technology that enables our operations teams to work with payers, enroll hard-to-engage members, and manage treatment operations for our network of full-time, specialty-trained therapists. Now, we feel the responsibility to leverage our Noto platform to scale other virtual specialties for severe, overlooked, but treatable conditions—starting with Rebound for PTSD.”

The Noto platform powers payer administrative functions, member identification & enrollment operations, and clinical training & management—often the biggest and most costly challenges faced by virtual specialty therapy services that focus on complex psychiatric and behavioral conditions. For example, partnerships with health plans nationwide are streamlined with AI-enabled revenue cycle management and purpose-built processes for credentialing and enrolling new therapists. To identify and engage Members of the OCD community, Noto powers awareness campaigns, personalized community feeds, self-help tools, and live events led by experts. And for NOCD’s 1000+ primarily full-time therapists, Noto houses AI-enabled clinical interviewing, a specialized training experience, continuous support and oversight, AI-assisted note-taking, Member communications, outcomes tracking, AI practice sessions, and more.

“As we worked to give our members a personalized, VIP treatment experience, we were limited by the off-the-shelf technology solutions that existed, so we set out to build the technological infrastructure we needed ourselves. After a decade of work, I can confidently say that Noto allows us to deliver a VIP treatment experience and more,” says Anil Vaitla, Cofounder and CTO of Noto and NOCD.

New specialties launched on Noto will be able to leverage support in these areas more quickly and easily. This is why NOCD’s acquisition of Rebound Health is a significant milestone. “Noto allows my cofounder, Dr. Erin Berenz, PhD, and me to scale a leading specialty therapy service for trauma survivors across the entire country,” says Raeva Kumar, Cofounder and CEO of Rebound Health. “As a trauma survivor who recovered by getting access to specialized treatment, I know firsthand the impact this makes.”

Having treated people with co-occurring OCD and PTSD for over three years, NOCD has a national network of over 100 licensed therapists with specialty training in Prolonged Exposure (PE) therapy for PTSD. This made the acquisition of Rebound, a self-help trauma recovery platform, seamless and impactful from day one.

Dr. Patrick McGrath, Chief Clinical Officer of Noto and NOCD, underscores the impact of Noto’s mission: “If Noto were to scale specialty therapy brands for five or more condition-specific populations that are complex, hidden, but treatable, we could rapidly drive better outcomes for tens of millions of people. This would then unlock the resources needed to invest in other complex conditions that are more difficult to treat. It could reduce so much suffering and strain on the healthcare system that today’s mental health crisis would be a thing of the past. We’d still have mental illnesses, but people with them wouldn’t be in crisis. That’s the kind of impact we’re striving to have.”

Looking ahead, Noto will power more specialties, like NOCD and Rebound, for complex, hidden, but treatable behavioral health populations. Doing so will reduce pressure on the mental healthcare system and unlock more resources for the most complex, hard-to-treat conditions, bringing hope that one day the mental health crisis will end.

About Noto:

Noto is an AI-enabled platform that’s transforming specialty therapy to end the mental health crisis. It’s a parent brand that develops and enables the operations to scale its virtual specialties for complex psychiatric and behavioral conditions: NOCD and, most recently, Rebound, with the expectation of more to come.